Clinical Trial Update: US Zamto-cel Autoimmune Diseases [Phase 1]

View source ↗

Summary

Miltenyi Biomedicine reports a Phase 1 trial of Zamto-cel for autoimmune diseases including lupus nephritis, systemic lupus erythematosus, systemic sclerosis, a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Cutaneous Systemic Sclerosis
• Lupus Nephritis
• Systemic Lupus Erythematosus
• Systemic Sclerosis

Drugs mentioned

• Zamto-cel

Snippet

Sponsor: Miltenyi Biomedicine GmbH | Conditions: Lupus Nephritis, Systemic Lupus Erythematosus | Phase 1 | Status: NOT_YET_RECRUITING